Dream Team targets molecular factors common in women's cancers

mdanderson has 392 videos Subscribe Here

Description: First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. MD Anderson's Gordon Mills explains.
Shared By : mdanderson
Posted on : 06/23/11
Added : 6 years ago
Category : Ovarian Cancer

More From mdanderson

Nothing found.